Loading
Life sciences · Interventional Study
ClinicalTrials.gov · October 6, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT06552637). This is a study registration, not published results. Lead sponsor: VisCardia Inc.. Recruitment status: RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 270 participants (ESTIMATED). Conditions: Heart Failure With Reduced Ejection Fraction. Interventions: DEVICE: Synchronized Diaphragmatic Stimulation. Primary outcome measures: Left ventricular End-Systolic Volume (LVESV) , 6 months; Six Minute Hall Walk (6MHW) , 6 months; Minnesota Living with Heart Failure quality of Life Score (MLWHF QOL) , 6 months; Major Adverse Respiratory and Cardiovascular Events (MARCE) , 6 months. Brief summary: RECOVER HF is a clinical study designed to evaluate the safety and efficacy of Synchronized Diaphragmatic Stimulation delivered using the VisONE System in the treatment of patients with heart failure.